Vaccine Vector
Interference with IL-1-signaling reduces toxicity of adenovirus vectors
Published in Gene Therapy Weekly, September 8th, 2005
According to a study from the United States, "The safety of gene therapy vectors is a major concern when novel viral or nonviral therapeutics are proposed for applications in humans. Adenovirus (Ad) vectors have been extensively used as efficient gene delivery vehicles in vitro over the last 2 decades. However, upon i.v. application, they elicit robust innate and inflammatory responses that may be fatal for the host. To date, the primary cytokines and chemokines involved in the initiation of these host responses remain illusive."
"In...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-09-08)
More Articles from Gene Therapy Weekly
- Colon Cancer
Genetic screen for candidate tumor suppressors identified REST - Gene Research
Company expands RNAi product line to 50,000 in frozen or plasmid DNA form - Muscular Dystrophy
No small feat: First ever gene therapy success for muscular dystrophy achieved - Parkinson Disease
Continuous delivery of GDNF optimizes neural transplantation therapy - Transplant Medicine
Akt a target for islet transplantation strategies in diabetics - Acute Myeloid Leukemia
Antiangiogenic treatment with endostatin successfully fights AML - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
